Late Recurrences of Cushing’s Disease after Initial Successful Transsphenoidal Surgery
Authors:
Open Access
- 1 February 2008
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (2) , 358-362
Abstract
Context: Few studies have systematically analyzed the long-term recurrence rates of Cushing’s disease after initial successful transsphenoidal surgery. Setting: This was a retrospective review of patients treated at the University of Virginia Medical Center. Patients: A total of 215 subjects with Cushing’s disease who underwent initial transsphenoidal surgery for resection of a presumed pituitary microadenoma from 1992–2006 were included. Main Outcome Measures: Remission and recurrence rates of Cushing’s disease were examined. Recurrence was defined as an elevated 24-h urine free cortisol with clinical symptoms consistent with Cushing’s disease. Results: Of the 215 patients who underwent transsphenoidal surgery for Cushing’s disease, surgical remission was achieved in 184 (85.6%). The mean length of follow-up was 45 months. Actuarial recurrence rates of Cushing’s disease after initially successful transsphenoidal surgery at 1, 2, 3, and 5 yr were 0.5, 6.7, 10.8, and 25.5%, respectively. Among the 184 patients who achieved remission, 32 (17.4%) patients followed for more than 6 months ultimately had a recurrence of Cushing’s disease. The median time to recurrence was 39 months. Immediate postoperative hypocortisolemia (serum cortisol ≤ 2 μg/dl within 72-h surgery) was achieved in 97 (45.1%) patients. Patients who had postoperative serum cortisol of more than 2 μg/dl were 2.5 times more likely to have a recurrence than patients who had serum cortisol less than or equal to 2 μg/dl (odds ratio = 2.5; 95% confidence interval 1.12–5.52; P = 0.022). Conclusions: A quarter of the patients with Cushing’s disease who achieve surgical remission after transsphenoidal surgery, recur with long-term follow-up. This finding emphasizes the need for continued biochemical and clinical follow-up to ensure remission after surgery.Keywords
This publication has 24 references indexed in Scilit:
- Mortality in Patients Treated for Cushing’s Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary MacroadenomaThe Journal of Clinical Endocrinology & Metabolism, 2007
- Surgical management of adrenocorticotropic hormone—secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndromeJournal of Neurosurgery, 2005
- Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression testJournal of Neurosurgery, 2003
- The neurosurgical management of Cushing's diseaseMolecular and Cellular Endocrinology, 2002
- Cushing's Case XLV: Minnie G.Journal of Neurosurgery, 2002
- Long‐term follow‐up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remissionClinical Endocrinology, 2002
- Cushing's SyndromeNew England Journal of Medicine, 1995
- Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of diseaseEuropean Journal of Endocrinology, 1994
- Predictive Factors for Initial Cure and Relapse Rate After Pituitary Surgery for Cushing’s DiseaseThe Journal of Clinical Endocrinology & Metabolism, 1989
- Transsphenoidal microsurgical management of Cushing's diseaseJournal of Neurosurgery, 1983